Acute and Chronic Therapies in Pediatric Inflammatory Central Nervous System Diseases
作者： Colin Wilbur , E. Yeh
关键词:
摘要: Recognition of pediatric neuroinflammatory disorders has increased in recent years, together with an knowledge the immune mechanisms underlying these disorders. These insights have led to paying greater attention classification disorders, and importantly, increasing information on therapeutic interventions that may improve outcomes. Furthermore, this occurred wake development multiple targeted therapies, thus creating a complex treatment landscape. This review aims summarize available literature regarding acute chronic therapies for inflammatory central nervous system (CNS) A standardized approach initial management diseases is presented.
thieme-connect.de参考文章(154)
Alex Gutierrez-Dalmau, Josep M Campistol, Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. ,vol. 67, pp. 1167- 1198 ,(2007) , 10.2165/00003495-200767080-00006
B Anlar, C Basaran, G Kose, A Guven, S Haspolat, A Yakut, A Serdaroglu, N Senbil, H Tan, E Karaagaoglu, K Karli Oguz, Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics. ,vol. 34, pp. 194- 199 ,(2003) , 10.1055/S-2003-42208
Niklas Schmedt, Frank Andersohn, Edeltraut Garbe, Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). Pharmacoepidemiology and Drug Safety. ,vol. 21, pp. 1216- 1220 ,(2012) , 10.1002/PDS.3320
Su-Hyun Kim, In Hye Jeong, Jae-Won Hyun, AeRan Joung, Hyo-Jin Jo, Sang-Hyun Hwang, Sooin Yun, Jungnam Joo, Ho Jin Kim, Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab JAMA Neurology. ,vol. 72, pp. 989- 995 ,(2015) , 10.1001/JAMANEUROL.2015.1276
Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Robert Zivadinov, GALA Study Group, None, Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis Annals of Neurology. ,vol. 73, pp. 705- 713 ,(2013) , 10.1002/ANA.23938
R. Robson, J.M. Cecka, G. Opelz, M. Budde, S. Sacks, Prospective Registry-Based Observational Cohort Study of the Long-Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate Mofetil American Journal of Transplantation. ,vol. 5, pp. 2954- 2960 ,(2005) , 10.1111/J.1600-6143.2005.01125.X
Anand Padmanabhan, Laura Connelly‐Smith, Nicole Aqui, Rasheed A. Balogun, Reinhard Klingel, Erin Meyer, Huy P. Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D. Zantek, Nancy M. Dunbar, Guest Editor: Joseph Schwartz, Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue Journal of Clinical Apheresis. ,vol. 34, pp. 149- 162 ,(2019) , 10.1002/JCA.21705
Jessica A. Panzer, Ronan Anand, Josep Dalmau, David R. Lynch, Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome. Journal of Neuroimmunology. ,vol. 286, pp. 86- 92 ,(2015) , 10.1016/J.JNEUROIM.2015.07.007
Nicholas Larkins, Siah Kim, Jonathan Craig, Elisabeth Hodson, Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children Archives of Disease in Childhood. ,vol. 101, pp. 404- 408 ,(2016) , 10.1136/ARCHDISCHILD-2015-308924
Marius Ringelstein, Ilya Ayzenberg, Jens Harmel, Ann-Sophie Lauenstein, Eckart Lensch, Florian Stögbauer, Kerstin Hellwig, Gisa Ellrichmann, Mark Stettner, Andrew Chan, Hans-Peter Hartung, Bernd Kieseier, Ralf Gold, Orhan Aktas, Ingo Kleiter, Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder. JAMA Neurology. ,vol. 72, pp. 756- 763 ,(2015) , 10.1001/JAMANEUROL.2015.0533